Bright Minds Biosciences Inc. (DRUG)
NASDAQ: DRUG · Real-Time Price · USD
74.23
-1.69 (-2.23%)
At close: Jul 16, 2026, 4:00 PM EDT
74.00
-0.23 (-0.31%)
After-hours: Jul 16, 2026, 6:44 PM EDT
Bright Minds Biosciences Market Cap
Bright Minds Biosciences has a market cap or net worth of $729.17 million as of July 16, 2026. Its market cap has increased by 322.57% in one year.
Market Cap
729.17M
Enterprise Value
508.64M
1-Year Change
322.57%
Ranking
Category
Stock Price
$74.23
ChartMarket Cap Chart
Since February 8, 2021, Bright Minds Biosciences's market cap has increased from $41.78M to $729.17M, an increase of 1,645.13%. That is a compound annual growth rate of 69.22%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 16, 2026 | 729.17M | 16.26% |
| Dec 31, 2025 | 627.18M | 150.23% |
| Dec 31, 2024 | 250.64M | 3,397.75% |
| Dec 29, 2023 | 7.17M | -49.18% |
| Dec 30, 2022 | 14.10M | -63.08% |
| Dec 31, 2021 | 38.19M | -8.59% |
| Feb 8, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Neurogene | 778.74M |
| Aura Biosciences | 772.10M |
| Zevra Therapeutics | 772.04M |
| Rigel Pharmaceuticals | 761.73M |
| Immix Biopharma | 760.31M |
| Omeros | 759.94M |
| Aclaris Therapeutics | 758.37M |
| Climb Bio | 758.13M |